<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01005381</url>
  </required_header>
  <id_info>
    <org_study_id>0609004386</org_study_id>
    <nct_id>NCT01005381</nct_id>
  </id_info>
  <brief_title>Effect of Calcium Supplement Particle Size and Vitamin D Supplement on Calcium Retention in Adolescent Girls</brief_title>
  <official_title>The Effect of Particle Size of Calcium Carbonate and Vitamin D on Calcium and Bone Parameters in Adolescent Girls</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Purdue University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Purdue University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study has two research arms:

      The purpose of the 1st is to determine if a smaller particle size calcium carbonate
      supplement (than that which is now commercially available) improves calcium absorption and
      retention in adolescents girls.

      The purpose of the 2nd is to determine if vitamin D supplementation improves calcium
      absorption and retention in adolescents girls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An important strategy to reducing the risk for osteoporosis and fracture in later life is to
      optimize the development of peak bone mass during adolescence. Because calcium is the main
      mineral component of bone, maximizing calcium absorption and retention during adolescence is
      important to maximize peak bone mass.

      Our two research arms address two different mechanisms by which calcium absorption and
      retention may be increased:

        1. We hypothesize that a smaller particle size calcium carbonate supplement (than that
           which is now commercially available) may be better absorbed and lead to higher calcium
           retention in adolescents.

        2. We hypothesize that vitamin D supplementation will increased calcium absorption and
           retention in adolescents.

      Subjects will be assigned to one of the two research arms.

      1)Small and large particle size calcium supplements or placebo or 2) calcium supplements with
      or without vitamin D supplements will be given to subjects during two 3-week study periods in
      which subjects live on-site.

      Calcium absorption will be measured by parathyroid hormone suppression after a calcium load
      and by stable calcium isotope in some subjects.

      Calcium retention will be measured by calcium intake minus calcium excretion.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">July 2007</completion_date>
  <primary_completion_date type="Actual">July 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Calcium Balance</measure>
    <time_frame>weeks 2,3 + 5,6</time_frame>
    <description>Total calcium(Ca) retention will be calculated - Ca retention/d = Ca intake/d - Ca excretion/d (urine + feces)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Calcium Absorption</measure>
    <time_frame>Day 15, 30</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum parathyroid hormone suppression</measure>
    <time_frame>Day 19, 40</time_frame>
    <description>Serum PTH will be measured by a 2-site immunoassay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum 25-hydroxyvitamin D</measure>
    <time_frame>Day 1, 20, 2, 41</time_frame>
    <description>Serum 25-hydroxyvitamin Dwill be measured by LCMS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Calcium</measure>
    <time_frame>Weeks 2,3 + 5,6</time_frame>
    <description>Ca content of all 24 h urine collections will be measured by Atomic Absorption Spectrophotometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal Calcium</measure>
    <time_frame>Weeks 2,3 + 5,6</time_frame>
    <description>Ca content of all fecal collections will be measured by Atomic Absorption Spectrophotometry</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">55</enrollment>
  <condition>Osteoporosis</condition>
  <arm_group>
    <arm_group_label>Small Particle Size Calcium Carbonate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects are given small particle size calcium carbonate supplement twice daily (total of 625 mg/d from supplement).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Large Particle Size Calcium Carbonate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects are given a large particle size calcium carbonate supplement twice daily (total of 625 mg/d from supplement).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Calcium Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects are given two placebo tablets daily, which are identical to the large and small particle size calcium carbonate supplements.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Vitamin D supplement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects are given calcium carbonate supplement once daily (325 mg/d from supplement).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects are given a calcium supplement once daily (325 mg/d from supplement) with 1000 IU/d vitamin D supplement.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Small Particle Size Calcium Carbonate Supplement</intervention_name>
    <description>Small Particle Size Calcium Carbonate - tablet, 325 mg/tablet. Given once or twice daily depending on study arm.</description>
    <arm_group_label>Small Particle Size Calcium Carbonate</arm_group_label>
    <arm_group_label>No Vitamin D supplement</arm_group_label>
    <arm_group_label>Vitamin D supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Large Particle Size Calcium Carbonate Supplement</intervention_name>
    <description>Large Particle Size Calcium Carbonate Supplement - tablet, 325 mg/tablet. Given twice daily.</description>
    <arm_group_label>Large Particle Size Calcium Carbonate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <description>Vitamin D - capsule, cholecalciferol, 1000 IU/tablet. Given once daily.</description>
    <arm_group_label>Vitamin D supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Calcium Placebo</intervention_name>
    <description>Placebo tablets identical to the large and small particle size calcium carbonate tablets.
Given twice daily.</description>
    <arm_group_label>Calcium Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  12-14 year old girls

          -  Generally Healthy

        Exclusion Criteria:

          -  History of alcohol, smoking, or non-prescription drug use

          -  Malabsorptive disorders, bone, liver, or kidney disease that may affect calcium
             metabolism

          -  Oral contraceptive use

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Connie M Weaver, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Purdue University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Purdue University</name>
      <address>
        <city>West Lafayette</city>
        <state>Indiana</state>
        <zip>47906</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 30, 2009</study_first_submitted>
  <study_first_submitted_qc>October 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2009</study_first_posted>
  <last_update_submitted>May 3, 2018</last_update_submitted>
  <last_update_submitted_qc>May 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Purdue University</investigator_affiliation>
    <investigator_full_name>Berdine Martin</investigator_full_name>
    <investigator_title>Research Scientist, Nutrition Science</investigator_title>
  </responsible_party>
  <keyword>Calcium</keyword>
  <keyword>Vitamin D</keyword>
  <keyword>Particle Size</keyword>
  <keyword>Adolescents</keyword>
  <keyword>Bone</keyword>
  <keyword>Osteoporosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Calcium Carbonate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

